BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38007380)

  • 21. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
    Hussain K; Mazza JJ; Clouse LH
    Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
    Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
    Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carfilzomib-associated tumor lysis syndrome.
    Shely RN; Ratliff PD
    Pharmacotherapy; 2014 May; 34(5):e34-7. PubMed ID: 24390940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk.
    Spina M; Nagy Z; Ribera JM; Federico M; Aurer I; Jordan K; Borsaru G; Pristupa AS; Bosi A; Grosicki S; Glushko NL; Ristic D; Jakucs J; Montesinos P; Mayer J; Rego EM; Baldini S; Scartoni S; Capriati A; Maggi CA; Simonelli C;
    Ann Oncol; 2015 Oct; 26(10):2155-61. PubMed ID: 26216382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review.
    Salter B; Burns I; Fuller K; Eshaghpour A; Lionel AC; Crowther M
    Eur J Haematol; 2022 Aug; 109(2):166-181. PubMed ID: 35531791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis.
    Lopez-Olivo MA; Pratt G; Palla SL; Salahudeen A
    Am J Kidney Dis; 2013 Sep; 62(3):481-92. PubMed ID: 23684124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Clinical Tumor Lysis Syndrome in a Patient with Mixed Phenotype Acute Leukemia Undergoing Induction with Venetoclax and Azacitidine: A Case Report.
    Drozd-Sokolowska J; Mądry K; Siewiorek K; Feliksbrot-Bratosiewicz M; Stokłosa T; Gierej B; Stefaniak A; Paszkowska-Kowalewska M; Sokołowski J; Sankowski B; Basak GW
    Chemotherapy; 2022; 67(3):173-177. PubMed ID: 35325891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report].
    He H; Li C; Han M
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):310-2. PubMed ID: 11721390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome.
    Kennedy LD; Ajiboye VO
    J Oncol Pharm Pract; 2010 Sep; 16(3):205-13. PubMed ID: 19923162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous tumor lysis syndrome in a child with T-cell acute lymphoblastic leukemia.
    Kobayashi D; Wofford MM; McLean TW; Lin JJ
    Pediatr Blood Cancer; 2010 May; 54(5):773-5. PubMed ID: 19998467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis.
    Goldman SC; Holcenberg JS; Finklestein JZ; Hutchinson R; Kreissman S; Johnson FL; Tou C; Harvey E; Morris E; Cairo MS
    Blood; 2001 May; 97(10):2998-3003. PubMed ID: 11342423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rasburicase in cancer-related hyperuricemia.
    Rodriguez M; Campara M; Haaf C
    Drugs Today (Barc); 2011 Aug; 47(8):591-603. PubMed ID: 21850282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Small Cell Lung Cancer.
    Koura S; Parekh V; Parikh AD; Kaur K; Dunn BK
    Cureus; 2023 Feb; 15(2):e34557. PubMed ID: 36879689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis.
    Feng X; Dong K; Pham D; Pence S; Inciardi J; Bhutada NS
    J Clin Pharm Ther; 2013 Aug; 38(4):301-8. PubMed ID: 23550846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X; Qing A; Ji P; French SW; Mason H
    Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous acute tumor lysis syndrome in acute myeloid leukemia? A single case report with discussion of the literature.
    Lotfi M; Brandwein JM
    Leuk Lymphoma; 1998 May; 29(5-6):625-8. PubMed ID: 9643577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous Tumor Lysis Syndrome in T-Cell Leukemia.
    Faheem B; Kollimuttathuillam S; Ashkar H; Maroules M
    Cureus; 2020 Oct; 12(10):e11002. PubMed ID: 33209558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour lysis syndrome: a rare side effect of imatinib therapy for GIST.
    Ondecker J; Kordic G; Jordan K
    BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor lysis syndrome.
    Jeha S
    Semin Hematol; 2001 Oct; 38(4 Suppl 10):4-8. PubMed ID: 11694945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCR-ABL Transcript Level as Compared to LDH and Uric Acid Among Chronic Myeloid Leukemic Patients.
    Hailemariam TS; Mehdi M; Kinde S; Seifu D; Edao A
    Recent Pat Anticancer Drug Discov; 2021; 16(3):445-455. PubMed ID: 33618649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.